Vol. 59 No. 3 (2020): Acta Oncologica

Articles

• Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma

  Kalle E. Mattila, Pia Vihinen, Susan Ramadan, Tanja Skyttä, Leena Tiainen, Meri-Sisko Vuoristo, Kristiina Tyynelä-Korhonen, Jussi Koivunen, Laura Kohtamäki, Siru Mäkelä, Micaela Hernberg

  310-314

  Published: 2020-03-03

  • PDF

• Validation of the Lymphoedema Quality of Life Questionnaire (LYMQOL) in Swedish cancer patients

  Madelene Wedin, Mats Fredrikson, Eva Ahlner, Annika Falk, Åsa Sandström, Gabriel Lindahl, Per Rosenberg, Preben Kjølhede

  365-371

  Published: 2020-03-03

  • PDF

• Item-level psychometrics of a brief self-reported memory problem screening measure in breast cancer survivors

  Pascal Jean-Pierre, Ying Cheng, Raheem J. Paxton

  358-364

  Published: 2020-03-03

  • PDF

• Parents’ needs of support following the loss of a child to cancer: a Swedish, prospective, longitudinal, multi-centre study

  Emma Hovén, Josefin Hagström, Ulrika Pöder, Helena Grönqvist, Louise von Essen

  351-357

  Published: 2020-03-03

  • PDF

• Demographic, clinical and lifestyle-related correlates of accelerometer assessed physical activity and fitness in newly diagnosed patients with head and neck cancer

  J. A. J. Douma, I. M. Verdonck-de Leeuw, C. R. Leemans, F. Jansen, J. A. Langendijk, R. J. Baatenburg de Jong, C. H. J. Terhaard, R. P. Takes, M. J. Chinapaw, T. M. Altenburg, L. M. Buffart

  342-350

  Published: 2020-03-03

  • PDF

• IMPROVE-IT2: implementing noninvasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer – intervention trial 2. Study protocol

  Jesper Nors, Tenna Vesterman Henriksen, Kåre Andersson Gotschalck, Therese Juul, Jes Søgaard, Lene Hjerrild Iversen, Claus Lindbjerg Andersen

  336-341

  Published: 2020-03-03

  • PDF

• Cutaneous adult T-cell leukemia/lymphoma presenting as sweet syndrome

  Alana Deutsch, Mark Jacobson, Beth N. McLellan

  334-335

  Published: 2020-03-03

  • PDF

• 17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based study

  Lindsay J. Collin, Sinna P. Ulrichsen, Thomas P. Ahern, Michael Goodman, Lauren E. McCullough, Lance A. Waller, Kristina Bang Christensen, Per Damkier, Stephen Hamilton-Dutoit, Kristina L. Lauridsen, Rami Yacoub, Peer M. Christiansen, Bent Ejlertsen, Henrik Toft Sørensen, Deirdre P. Cronin-Fenton, Timothy L. Lash

  329-333

  Published: 2020-03-03

  • PDF

• Patients’ preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406

  Go Makimoto, Katsuyuki Hotta, Isao Oze, Kiichiro Ninomiya, Masamoto Nakanishi, Naofumi Hara, Hirohisa Kano, Hiromi Watanabe, Yusuke Hata, Kazuya Nishii, Takamasa Nakasuka, Junko Itano, Takashi Ninomiya, Toshio Kubo, Kadoaki Ohashi, Eiki Ichihara, Daisuke Minami, Akiko Sato, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura

  324-328

  Published: 2020-03-03

  • PDF

• Delay in adjuvant chemoradiation impacts survival outcome in glioblastoma multiforme patients

  Mahadev Potharaju, Anugraha Mathavan, Balamurugan Mangaleswaran, Siddhartha Ghosh, Reginald John

  320-323

  Published: 2020-03-03

  • PDF

• Carcinoid heart failure in a duodenal neuroendocrine tumor: role of cardiac surgery in a challenging patient and brief review of the literature

  Anna La Salvia, Maria Pia Brizzi, Elena Trevisi, Francesco Parisi, Leonardo Muratori, Francesco Atzeni, Massimo Di Maio, Giorgio V. Scagliotti

  315-319

  Published: 2020-03-03

  • PDF

• Immune checkpoint inhibitors in cancer treatment and potential effect modification by age

  Hanna Eriksson, Karin E. Smedby

  247-248

  Published: 2020-03-03

  • PDF

• Regenerative nodular hyperplasia after T-DM1: consequences from sinusoidal endothelium damages

  Soraya Benguerfi, Véronique Diéras, Mario Campone, Jean-François Mosnier, Marie Robert

  306-309

  Published: 2020-03-03

  • PDF

• Successful treatment of central nervous system involved Erdheim–Chester disease by intermediate-dose cytarabine as first-line therapy

  Ji-Nuo Wang, Yu Qiu, Na Niu, Yan Zhang, Jian Li, Dao-bin Zhou, Xin-Xin Cao

  302-305

  Published: 2020-03-03

  • PDF

• Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers

  Lars H. Jensen, Rikke Fredslund Andersen, Lene Byriel, Eva Fernebro, Anders Jakobsen, Jan Lindebjerg, Lise Nottelmann, John Ploen, Torben F. Hansen

  298-301

  Published: 2020-03-03

  • PDF

• Impact of body fat distribution and sarcopenia on the overall survival in patients with spinal metastases receiving radiotherapy treatment: a prospective cohort study

  B. J. Pielkenrood, P. R. van Urk, J. M. van der Velden, N. Kasperts, J. J. C. Verhoeff, G. H. Bol, H. M. Verkooijen, J. J. Verlaan

  291-297

  Published: 2020-03-03

  • PDF

• Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study

  Artur Mezheyeuski, Fredrik Ponten, Per-Henrik Edqvist, Magnus Sundström, Ulf Thunberg, Camilla Qvortrup, Per Pfeiffer, Halfdan Sorbye, Bengt Glimelius, Anca Dragomir

  284-290

  Published: 2020-03-03

  • PDF

• Knowledge-based planning for oesophageal cancers using a model trained with plans from a different treatment planning system

  Yoshihiro Ueda, Masayoshi Miyazaki, Iori Sumida, Shingo Ohira, Mikoto Tamura, Hajime Monzen, Haruhi Tsuru, Shoki Inui, Masaru Isono, Kazuhiko Ogawa, Teruki Teshima

  274-283

  Published: 2020-03-03

  • PDF

• High RSF1 protein expression is an independent prognostic feature in prostate cancer

  Doris Höflmayer, Moslim Hamuda, Cornelia Schroeder, Claudia Hube-Magg, Ronald Simon, Cosima Göbel, Andrea Hinsch, Sören Weidemann, Katharina Möller, Jacob R. Izbicki, Frank Jacobsen, Tim Mandelkow, Niclas C. Blessin, Florian Lutz, Florian Viehweger, Guido Sauter, Eike Burandt, Patrick Lebok, Maximilian Lennartz, Christoph Fraune, Sarah Minner, Sarah Bonk, Hartwig Huland, Markus Graefen, Thorsten Schlomm, Franziska Büscheck

  268-273

  Published: 2020-03-03

  • PDF

• Terminal digit preference: a source of measurement error in breast cancer diameter reporting

  Kaitlyn M. Tsuruda, Solveig Hofvind, Lars A. Akslen, Solveig R. Hoff, Marit B. Veierød

  260-267

  Published: 2020-03-03

  • PDF

• Clinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels

  A. Sibille, M. Henket, J. L. Corhay, R. Louis, B. Duysinx

  257-259

  Published: 2020-03-03

  • PDF

• Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis

  Kiichiro Ninomiya, Isao Oze, Yuka Kato, Toshio Kubo, Eiki Ichihara, Kammei Rai, Kadoaki Ohashi, Toshiyuki Kozuki, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura, Katsuyuki Hotta

  249-256

  Published: 2020-03-03

  • PDF